Randomized controlled trial of Cassia alata Linn. for constipation.
V Thamlikitkul, N Bunyapraphatsara, T Dechatiwongse...
https://pubmed.ncbi.nlm.nih.gov/2203870/Actively Recruiting
Led by The University of The West Indies · Updated on 2025-11-19
20
Participants Needed
1
Research Sites
47 weeks
Total Duration
Researchers are evaluating the clinical effectiveness and safety of a 20% Cassia alata extract cream for treating tinea versicolor, a common superficial fungal skin infection also known as pityriasis versicolor. The study aims to determine whether applying this traditional remedy helps clear the infection better than leaving the skin untreated and to assess any side effects from its use. This is a Phase 1 pilot trial conducted by The University of The West Indies. Participants will apply a thin layer of the Cassia alata cream twice daily to a designated treatment area on the skin, using 1-2 fingertip units to cover the affected site, leaving other areas untreated for comparison. The cream application is spaced at least 8 hours apart. The study involves a single-arm, no-treatment self-controlled design where treated areas are compared against untreated areas. Follow-up visits are scheduled every 4 weeks for a total of 12 weeks. During the study, participants will undergo clinical examinations, fungal scrapings, and Woods lamp evaluations at baseline, 1 week, 4 weeks, 8 weeks, and 12 weeks to assess lesion clearance and fungal load. Researchers will monitor local skin reactions and document side effects and ease of use. Demographic data and clinical findings will be analyzed to evaluate the treatments effect and safety profile over the 12-week period.
CONDITIONS
A Study of the Clinical Efficacy and Safety of 20% Cassia Alata Extract Against Tinea Versicolor
M
Marvin Reid, MB Bs PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
The University of The West Indies
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 12 weeks
Participants apply 20% Cassia alata cream to designated treatment areas while leaving other areas untreated as controls. Clinical and microbiological assessments are performed to evaluate lesion clearance and fungal load.
Visits at baseline, Week 1, Week 4, Week 8, and Week 12
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
V Thamlikitkul, N Bunyapraphatsara, T Dechatiwongse...
https://pubmed.ncbi.nlm.nih.gov/2203870/S Damodaran, S Venkataraman
https://pubmed.ncbi.nlm.nih.gov/8046939/S K Agarwal, S S Singh, S Verma...
https://pubmed.ncbi.nlm.nih.gov/10967452/Joseph R Kallini, Fauzia Riaz, Amor Khachemoune
https://pubmed.ncbi.nlm.nih.gov/24320140/Aditya K Gupta, Danika C A Lyons
https://pubmed.ncbi.nlm.nih.gov/24991691/S Palanichamy, S Nagarajan
https://pubmed.ncbi.nlm.nih.gov/2214817/Dongdong Zhang, Yao Fu, Jun Yang...
https://pubmed.ncbi.nlm.nih.gov/31212847/B Barros Cota, D Batista Carneiro de Oliveira, T Carla Borges...
https://pubmed.ncbi.nlm.nih.gov/32654270/Takamasa Kaneko, Koichi Makimura, Masanobu Onozaki...
https://pubmed.ncbi.nlm.nih.gov/16422299/The University of The West Indies
Lead Sponsor